Status:
COMPLETED
Iterative Beta Testing of Videos for the DIPPer Academy
Lead Sponsor:
University of Kansas Medical Center
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Type1diabetes
Eligibility:
All Genders
3-65 years
Phase:
NA
Brief Summary
The purpose of this research is to develop DIPPer Academy, a parent-focused, mobile health (mHealth) behavioral intervention to promote glycemic control in young children.
Detailed Description
Because many young children with T1D have glucose levels that exceed targets, investigators need to develop efficacious, accessible, and readily disseminable interventions to help them to improve thei...
Eligibility Criteria
Inclusion
- Parents of a young child who is between 3-5.99 years old and at least 6 months post T1D diagnosis
- Parents who are English-speaking.
Exclusion
- Parents of young children with evidence of type 2 diabetes or monogenic diabetes.
- Parents with evidence of severe psychiatric disorder.
- Parents of young children with a comorbid chronic illness (e.g., renal disease) that requires ongoing care beyond T1D.
- Parents of young children with a history of anemia or medication use that may interact with glycemic control (e.g., systemic steroids).
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2021
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT03385265
Start Date
January 1 2018
End Date
September 1 2021
Last Update
March 11 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160
2
The Children's Mercy Hospital
Kansas City, Missouri, United States, 64108